Major depressive disorder Trials in Toms River, United States
Conditions / Major depressive disorder / Toms River, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
31 total trials for this combination
Showing top 10 of 31 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01152554 | A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01156415 | Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT01436175 | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study | TERMINATED | PHASE3 |
| NCT04855747 | A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT04019704 | A Trial of AXS-05 in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT04039022 | Open-Label Safety Study of AXS-05 in Subjects With Depression | COMPLETED | PHASE3 |
| NCT00278941 | Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT06029439 | Study to Assess the Safety and Effectiveness of NMRA-335140-501 | RECRUITING | PHASE3 |
| NCT06011577 | Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD | TERMINATED | PHASE3 |
| NCT01153347 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |